CompletedInterventionalPhase 4Last updated Dec 9, 2016

Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

A Randomized, Double-blind, Placebo-controlled, Active Comparator, One-Week, Cross-Over, Multicenter Study to Evaluate the Efficacy and Patient Preference of Nasal Spray Characteristics of Once-Daily, Intranasal Administration of 110mcg Fluticasone Furoate Nasal Spray and 200mcg Fluticasone Propionate Nasal Spray in Adult Subjects With Seasonal Allergic Rhinitis

Overview

ClinicalTrials.gov ID: NCT00539006
Lead Sponsor: GlaxoSmithKlineINDUSTRY
Brief Summary: The purpose of this replicate study to FFU105927 is to provide data on subject preference of FFNS as compared with FPNS.
Study Type: Interventional

Status

Overall Status: Completed
Start Date: Aug 2007
Primary Completion Date: Nov 2007Actual
Completion Date: Nov 2007Actual

Study Record Dates

First Submitted: Oct 2, 2007
First Submitted that Met QC Criteria: Oct 2, 2007
First Posted: Oct 3, 2007Estimated
Last Update Submitted that Met QC Criteria: Oct 27, 2016
Last Update Posted: Dec 9, 2016Estimated
Last Verified: Oct 2016

NCT00519636Completed

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

NCT00398476Completed

Fluticasone Nasal Spray Patient Preference Study

NCT02397915Completed

Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays

NCT02424539Completed

A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)

NCT01916226Completed

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

NCT00783224Completed

A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)